Optically active β-hydroxy-α-amino acids are an important class of amino acids as they are structural motifs in many biologically active natural products such as vancomycin,[@cit1] katanosins,[@cit2] cyclosporin,[@cit3] myriocin,[@cit4a],[@cit4b] mycestericins,[@cit4c],[@cit4d] sphingosine and threonine ([Fig. 1](#fig1){ref-type="fig"}). Furthermore, these amino acids are also useful chiral building blocks in organic synthesis as precursors to β-lactams,[@cit5] β-halo-α-amino acids,[@cit6] and aziridines.[@cit7] A variety of catalytic asymmetric approaches for the synthesis of β-hydroxy-α-amino acids has been reported.[@cit8]--[@cit14] In a pioneering study,[@cit8a] Ito, Hayashi and coworkers reported a gold-catalyzed highly diastereoselective and enantioselective aldol reaction for the generation of β-hydroxy-α-amino acids containing tertiary α-carbons. Since then other groups have also reported asymmetric direct aldol reactions with chiral transition-metal catalysts,[@cit8c]--[@cit8h] organocatalysts[@cit9] and aldolases[@cit10] for the synthesis of β-hydroxy-α-amino acids and their derivatives. In addition, Sharpless asymmetric aminohydroxylation,[@cit11] transition-metal-catalyzed asymmetric hydrogenation,[@cit12] palladium-catalyzed allylic alkylation[@cit13] and chiral phosphoric acid-catalyzed addition to oxocarbenium ion[@cit14] have been utilized to achieve the same goal.

![Mycestericins: potent immunosuppressant natural products](c5sc02116b-f1){#fig1}

We became interested in the development of catalytic asymmetric synthesis of β-hydroxy-α-amino acids because biologically interesting natural products such as mycestericins contain a chiral β-hydroxy-α-amino acid motif that could not be constructed from existing catalytic asymmetric aldol reactions. In particular this motif presents both a tertiary β-stereocenter and a quaternary α-stereocenter with alkyl substituents. In principle, an efficient catalytic asymmetric aldol reaction of α-alkyl enolates or the equivalents with aliphatic aldehydes could provide a direct access to this structural motif.[@cit15] However, to our knowledge, such an asymmetric transformation was not available. Herein, we report the first efficient catalytic asymmetric direct aldol reaction of α-alkyl azlactones **6** and aliphatic aldehydes **7** ([Scheme 1](#sch1){ref-type="fig"}), which provides, to our knowledge, the first useful asymmetric catalytic access toward β-hydroxy-α-amino acids bearing alkyl substituents at both the tertiary β-stereocenter and the quaternary α-stereocenter. The high *anti*-diastereoselectivity in combination with a broad substrate scope allows the reaction to complement existing methods to form a general strategy for the asymmetric synthesis of β-hydroxy-α-amino acids.

![Reaction design](c5sc02116b-s1){#sch1}

We initiated our study by reacting azlactone **6a** and aldehyde **7a** in the presence of a stoichiometric amount of triethylamine. After considerable experiments, we found that a reaction could be reasonably fast and clean at --20 °C in chloroform. We next investigated the possibility of promoting an asymmetric variant of this reaction with cinchona alkaloid-derived catalysts ([Fig. 2](#fig2){ref-type="fig"}). Upon first screening of a series cinchona alkaloid derivatives, (entries 1--9, [Table 1](#tab1){ref-type="table"}), we identified the 6′-OH cinchona alkaloid **3d** as the most promising catalyst in terms of affording high diastereoselectivity and enantioselectivity (entry 6, [Table 1](#tab1){ref-type="table"}). Catalyst **3e**, the pseudo-enantiomer of **3d**, gave comparable results with an expected reverse sense of asymmetric induction (entry 7, [Table 1](#tab1){ref-type="table"}). Following these results, we carried out the **3d**-promoted aldol reaction in a variety of solvents with azlactone **6a** at a significantly decreased concentration of 0.5 M (entry 10--15). We found that the reaction at the reduced concentration proceeded in higher diastereo- and enantioselectivity (entry 10 *vs.* 6). Moreover, the reaction in dichloromethane occurred in a slightly higher diastereoselectivity than and the same enantioselectivity as the reaction in chloroform (entries 11--10, [Table 1](#tab1){ref-type="table"}). Both the diastereoselectivity and enantioselectivity afforded by catalyst **3d** could be improved significantly when the reaction was performed at significantly reduced temperature and concentration (entry 16 *vs.* 11), although a higher catalyst loading and an extended reaction time were required for the reaction to proceed to completion. Importantly, under these conditions, a highly diastereoselective and enantioselective aldol reaction was established to generate the desired aldol product **8aa** in 92% isolated yield, 94% ee and 97.5/2.5 *anti*/*syn* ratio. It should be noted that no product resulted from the self-aldol reaction by aldehyde **7a** was detected by NMR analysis.

![Cinchona alkaloid catalysts](c5sc02116b-f2){#fig2}

###### Catalytic asymmetric aldol reaction of azlactone **6a** and aldehyde **7a**[^*a*^](#tab1fna){ref-type="fn"}

  ![](c5sc02116b-u1.jpg){#ugr1}                                                                                                                                                                 
  ------------------------------------------------------------------------------------ -------- -------------------- ------ ------ ------------------------------------------------- ---------- -----------
  1                                                                                    **1**    CHCl~3~ (2 M)        --20   15 h   \>95                                              29/22      43.5/56.5
  2                                                                                    **2**    CHCl~3~ (2 M)        --20   15 h   93                                                43/12      40.5/59.5
  3                                                                                    **3a**   CHCl~3~ (2 M)        --20   15 h   \>95                                              57/25      81/19
  4                                                                                    **3b**   CHCl~3~ (2 M)        --20   15 h   \>95                                              51/19      73/27
  5                                                                                    **3c**   CHCl~3~ (2 M)        --20   15 h   92                                                --7/18     71/29
  6                                                                                    **3d**   CHCl~3~ (2 M)        --20   15 h   \>95                                              75/13      88/12
  7                                                                                    **3e**   CHCl~3~ (2 M)        --20   15 h   \>95                                              --73/16    90/10
  8                                                                                    **4**    CHCl~3~ (2 M)        --20   15 h   91                                                --64/--6   82/18
  9                                                                                    **5**    CHCl~3~ (2 M)        --20   15 h   \>95                                              --71/22    66/34
  10                                                                                   **3d**   CHCl~3~ (0.5 M)      --20   34 h   95                                                86/--11    91/9
  11                                                                                   **3d**   CH~2~Cl~2~ (0.5 M)   --20   34 h   93                                                86/--39    93.5/6.5
  12                                                                                   **3d**   PhCH~3~ (0.5 M)      --20   34 h   80                                                48/--28    80/20
  13                                                                                   **3d**   THF (0.5 M)          --20   34 h   \>95                                              50/--28    79.5/20.5
  14                                                                                   **3d**   Et~2~O (0.5 M)       --20   34 h   \>95                                              53/--28    83/17
  15                                                                                   **3d**   CH~3~CN (0.5 M)      --20   34 h   \>95                                              72/--18    88/12
  16[^*e*^](#tab1fne){ref-type="table-fn"} ^,^[^*f*^](#tab1fnf){ref-type="table-fn"}   **3d**   CH~2~Cl~2~ (0.1 M)   --50   88 h   \>95 (92)[^*b*^](#tab1fnb){ref-type="table-fn"}   94/ND      97.5/2.5

^*a*^Reactions were carried out with 0.1 mmol of **6a** and 0.15 mmol of **7a**.

^*b*^Isolated yield.

^*c*^Determined by chrial HPLC analysis.

^*d*^ee (*anti*/*syn*).

^*e*^10 mg of 4 Å molecular sieves were added.

^*f*^15 mol% of **3d**.

Applying the optimized reaction conditions for the model reaction, we investigated the substrate scope of this asymmetric aldol reaction ([Table 2](#tab2){ref-type="table"}). The reactions of aldehyde **7a** and azlactones **6a--g** bearing different α-alkyl substituents gave consistently excellent yields, enantioselectivity and *anti*-selective diastereoselectivity (entries 1--7, [Table 2](#tab2){ref-type="table"}). The catalyst could also accommodate variations in aliphatic aldehydes as shown by its high efficiency in the promotion of asymmetric aldol reactions involving a series of aliphatic aldehydes (entries 8--11, [Table 2](#tab2){ref-type="table"}). The tolerance of aldehyde **7d**, which bears a linear C12 alkyl chain, is noteworthy. With catalyst **3e**, the reaction provide equally efficient access to the other enantiomer of the aldol product, as shown in the formation of aldol adduct *ent*-**8ba**, *ent*-**8bc** and *ent*-**8dc** (entries 2, 9, 10, [Table 2](#tab2){ref-type="table"}). As detailed in the ESI,[†](#fn1){ref-type="fn"} the relative and absolute configurations of aldol products **8** were determined by 1D NOESY experiment and a modified Mosher\'s method, respectively.[@cit16]

###### Scope of reaction[^*a*^](#tab2fna){ref-type="fn"} [^*b*^](#tab2fnb){ref-type="fn"} [^*e*^](#tab2fne){ref-type="fn"}

  -------------------------------
  ![](c5sc02116b-u2.jpg){#ugr2}
  -------------------------------

^*a*^Unless noted, reactions were carried out with 0.1 mmol of **6**, 0.15 mmol of **7**, 0.015 mmol of **3d**, 10 mg of 4 Å molecular sieves in 1 mL of dichloromethane.

^*b*^ee value and *anti*/*syn* ratio determined by chiral HPLC analysis.

^*c*^0.2 mmol of **7b**.

^*d*^Results in parentheses obtained using **3e** (15 mol%) as catalyst.

^*e*^See ESI for determination of relative and absolute configurations.

To demonstrate the potential synthetic utility of the chiral aldol adduct **8**, ring opening transformations converting **8** into useful β-hydroxy-α-amino acid derivative **10** must be developed. We found that **8** were liable toward retro-aldol initiated decompositions under a variety of reaction conditions. After extensive experimental explorations, we were able to establish a high yield, three-step protocol to convert **8** into β-hydroxy-α-aminoester **10** ([Scheme 2](#sch2){ref-type="fig"}). Critical to the development of this useful conversion was the experimental discovery that the THP protected β-hydroxy-α-alkylazlactones **9**, unlike **8**, is inert toward retro-aldol decompositions.[@cit17] It should be noted that the four-step enantioselective preparations of β-hydroxy-α-aminoester **10** from azlactones **6** and aldehydes **7** require only a single purification for the isolation of **10**, both intermediates **8** and **9** were used for the next step without subjecting to purifications. To establish enantioselective access to all four stereoisomers of β-hydroxy-α-amino acid derivative **10**, we developed a one-pot conversion of *anti*-β-hydroxy-α-amino acid **10da** into the corresponding *syn*-β-hydroxy-α-amino acid *syn*-**12da** involving the treatment of *anti*-**10da** with thionyl chloride followed by HCl in THF ([Scheme 2](#sch2){ref-type="fig"}).

![Transformation of aldol product **8**. Reagents and conditions: (a) **3d** (15 mol%), CH~2~Cl~2~, 4 Å MS, --50 °C; (b) PPTS, DHP, CH~2~Cl~2~, rt; then K~2~CO~3~, Na~2~SO~4~, MeOH, rt; (c) 2 N HCl, MeOH, rt; (d) HCl in MeOH (∼1.25 M), rt; (e) SOCl~2~, THF, rt; (f) 2 N HCl, THF, rt; (g) **3e** (15 mol%), CH~2~Cl~2~, 4 Å MS, --50 °C. PPTS = pyridinum-*p*-toluenesulfonate; DHP = 3,4-dihydro-2-*H*-pyran.](c5sc02116b-s2){#sch2}

Conclusions
===========

In summary, we have developed a highly enantioselective and diastereoselective direct aldol reaction of α-alkyl azlactones with aliphatic aldehydes catalyzed by cinchona alkaloid catalysts **3d** and **3e**. To our knowledge, this is the first efficient asymmetric direct aldol reaction of azlactones and aliphatic aldehydes. Providing an efficient catalytic asymmetric access to β-hydroxy-α-amino acids bearing alkyl substituents at both the tertiary β-stereocenter and the quaternary α-stereocenter, this new catalytic asymmetric aldol reaction should find applications in natural product synthesis and medicinal chemistry.[@cit18]
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